Raymond James Financial Services Advisors, Inc. Shattuck Labs, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$7.37 - $10.09 $134,443 - $184,061	18,242 New	18,242 $163,000
Q4 2021 Feb 08, 2022	SELL	$8.36 - $21.08 $88,515 - $223,195	-10,588 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$24.14 - $37.68 $255,594 - $398,955	10,588 New	10,588 $307,000

Others Institutions Holding STTK

# of Institutions

Shares Held

28.8M

Call Options Held

300

Put Options Held

1.2K

Prosight Management, LP Dallas, TX

5.68M
Shares

$6.25 Million
5.32% of portfolio
Redmile Group, LLC San Francisco, CA

5.62M
Shares

$6.18 Million
1.28% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

2.9M
Shares

$3.19 Million
0.02% of portfolio
Black Rock Inc. New York, NY

2.47M
Shares

$2.72 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.4M
Shares

$2.64 Million
0.0% of portfolio

View Full List

About Shattuck Labs, Inc.

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $46.6M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

More about STTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account